[email protected]

Foresight Diagnostics Announces the Hiring of Sandra Close, Ph.D., as Chief Operations Officer

Apr 04, 2022

Foresight Diagnostics today announced the hiring of Sandra Close, Ph.D., as Chief Operations Officer (COO). Sandra brings extensive experience in delivering drugs and diagnostics, with a focus on organizational structure, business strategy, and quality and regulatory requirements. Dr. Close has served as an executive leader in both diagnostic and pharmaceutical companies, including at ArcherDX/Invitae and Eli Lilly, among others.

“Sandy has been guiding pharmaceutical and biotechnology corporations to successful development of novel technologies and regulated products for many years,” said Jake Chabon, Ph.D., co-founder and Chief Executive Officer of Foresight Diagnostics…

Read the full article on PR Newswire.


Share this page on social

Ready to get started? See what Samba can do for you.